INSIGHTS ON CLINICAL TRIAL DESIGN
-
![Senior patient gazing out window in hospital room (high res)]( "Mastering Precision Oncology Start-Up: Reducing Screening Delays")
Mastering Precision Oncology Start-Up: Reducing Screening DelaysBiomarker-driven trials create intricate screening hurdles. Explore creative, practical ways to accelerate start‑up, boost enrollment, and power precision oncology studies forward with greater speed.
-
![GettyImages-1903972230 Sustainability Concept, Green Forest With Globe Earth]( "Mastering Scope 3 Emissions In Clinical Trials")
Mastering Scope 3 Emissions In Clinical TrialsExplore innovative strategies for reducing Scope 3 emissions in clinical trials. Discover sustainable solutions that uphold quality and outcomes, crucial for achieving net-zero goals in healthcare research.
-
![etech-clinical-GettyImages-1413603540]( "Elosity's Agile RTSM Build Experience")
Elosity's Agile RTSM Build ExperienceModern RTSM requires agility. Learn how real-time visibility, flexible configuration, and faster amendments help teams execute studies with greater efficiency.
-
![Checking prescription on smartphone-GettyImages-1719535353]( "Wearable Data Is Only Useful If It's There: Helping You Collect Your Study Data")
Wearable Data Is Only Useful If It's There: Helping You Collect Your Study DataNew, proactive alerts on this digital health platform ensure complete and high-quality data collection from wearable devices in clinical trials.
-
Podcast―Nonclinical Considerations When Developing Ophthalmic Drugs2/20/2025
Globally recognized consultants discuss how they are addressing the most pressing drug development topics in the ocular field.
-
Challenges To Making Go/No-Go Decisions In Clinical Trials7/16/2026
In drug development, a go/no-go decision can be a high-stakes trade-off between speed and certainty. Delve into the real-world operational and strategic hurdles to making those decisions.
-
Flexible By Design: Support For Early-Phase Oncology Trial7/8/2026
Shifting cohorts, doses, and protocols challenge early-phase oncology trials. Learn how adaptable technology keeps studies on track.
-
Start-Up Speed vs. Total Trial Success: Balancing RTSM Priorities3/9/2026
Don't let a fast startup compromise years of clinical success. Learn how to balance initial build speed with the long-term flexibility needed to handle protocol amendments and complex integrations.
-
Leading Recruitment With A Strong Alzheimer's Referral Pool2/24/2026
A strong referral network helped the Gainesville site rapidly recruit pTau217‑positive Alzheimer’s participants while upholding high data quality, boosting enrollment and outperforming other sites.
CLINICAL TRIAL DESIGN SOLUTIONS
-
![rules, policies, regulatory documents-GettyImages-1438925546]( "Are You Preparing For First-In-Human Clinical Trials?")
Reach critical first-in-human milestones faster with experienced teams, rapid study start-up, and real-time data that reduce complexity, inform decisions, and de-risk development.
-
![Milestone-concept-GettyImages-871890160]( "RTSM Solutions That Adapt To Your Needs")
At Endpoint Clinical, our solutions proactively problem-solve. We expect the unexpected, so you can focus on reaching key clinical trial milestones.
-
![clinical-trials-patients-GettyImages-1629549075]( "An Experienced Endocrinology And Metabolic Partner")
Accelerate endocrinology and metabolic trials. Discover global regulatory strategies, decentralized models, and patient-centric recruitment data to optimize your clinical development.
-
![Brain]( "Trialtrove: The Most Trusted, Comprehensive & Reliable Clinical Trial Intelligence")
Trialtrove is the industry's go-to resource to support and inform clinical trial strategy, design and execution. Our expert analysts provide insights into trial timing benchmarks, enrollment successes and failures, accrual details and study results.
-
![GettyImages-2176126405-digital-puzzle]( "First-In-Human To Proof-Of-Concept: The DVCR Continuity Model")
With a single, consistent team from FIH to Proof-of-Concept, this Continuity Model eliminates fragmented handoffs to keep program knowledge intact and speed your path to Phase II.
